The Oral Iron Chelator Deferiprone Protects against Iron Overload–Induced Retinal Degeneration
Majda Hadziahmetovic(Penn Presbyterian Medical Center), Joshua L. Dunaief(Penn Presbyterian Medical Center), Arkady Lyubarsky(Penn Presbyterian Medical Center), Z. Leah Harris(Dell Children's Medical Center of Central Texas), Natalie Wolkow(Ophthalmology Associates (United States)), Michael Spino, Domenico Praticò(University of Pennsylvania), Steven F. Grieco(University of California, Irvine), Jared Iacovelli(Penn Presbyterian Medical Center), Jennifer Lee(The Catholic University of Korea Seoul St. Mary's Hospital), Ying Song(Xijing Hospital), John Connelly(Queen Mary University of London)
Cited by 118
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|864
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.
|Proceedings of the National Academy of Sciences|1995|556
Phototransduction in transgenic mice after targeted deletion of the rod transducin α-subunit
|Proceedings of the National Academy of Sciences|2000|379